Cargando…

Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis

BACKGROUND: There are substantial advances in diagnosis and treatment for idiopathic pulmonary fibrosis (IPF), but without much evidence available on recent mortality and survival trends. METHODS: A narrative synthesis approach was used to investigate the mortality trends, then meta-analyses for sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Qiang, Cox, Ingrid A., Campbell, Julie A., Xia, Qing, Otahal, Petr, de Graaff, Barbara, Corte, Tamera J., Teoh, Alan K.Y., Walters, E. Haydn, Palmer, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918939/ https://www.ncbi.nlm.nih.gov/pubmed/35295232 http://dx.doi.org/10.1183/23120541.00591-2021

Ejemplares similares

The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study
por: Cox, Ingrid A., et al.
Publicado: (2022)

Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
por: Cox, Ingrid A., et al.
Publicado: (2022)

The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study
por: Zheng, Qiang, et al.
Publicado: (2023)

Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis
por: Cox, Ingrid A., et al.
Publicado: (2020)

Importance of Occupational Exposure Data: A National Idiopathic Pulmonary Fibrosis Registry Perspective
por: Teoh, Alan K. Y., et al.
Publicado: (2020)

There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)
por: Nambiar, Shabarinath, et al.
Publicado: (2021)

Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis
por: Humphries, Stephen M., et al.
Publicado: (2022)

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
por: Jo, Helen E., et al.
Publicado: (2018)

Patient Registries in Idiopathic Pulmonary Fibrosis
por: Culver, Daniel A., et al.
Publicado: (2019)

Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
por: Corte, Tamera, et al.
Publicado: (2015)

Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2023)

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial
por: Noth, Imre, et al.
Publicado: (2021)

The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review
por: Lee, Joanna Y.T., et al.
Publicado: (2020)

A Comprehensive Systematic Review of Data Linkage Publications on Diabetes in Australia
por: Dinh, Ngan T. T., et al.
Publicado: (2022)

Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system
por: Xia, Qing, et al.
Publicado: (2021)

An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery
por: Campbell, Julie A., et al.
Publicado: (2017)

Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
por: Kreuter, Michael, et al.
Publicado: (2016)

In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study
por: Durheim, Michael T., et al.
Publicado: (2019)

Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine
por: Christian, Katherine, et al.
Publicado: (2022)

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
por: Corte, Tamera J, et al.
Publicado: (2021)

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
por: Oldham, Justin M., et al.
Publicado: (2023)

Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema
por: Zhao, An, et al.
Publicado: (2021)

Essential need for rethink of COPD airway pathology: implications for new drug approaches for prevention of lung cancer as well as small airway fibrosis
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2017)

Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World
por: Polke, Markus, et al.
Publicado: (2021)

A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018
por: Durheim, Michael T., et al.
Publicado: (2020)

Association between weight loss and mortality in idiopathic pulmonary fibrosis
por: Kalininskiy, Aleksandr, et al.
Publicado: (2022)

Automated airway quantification associates with mortality in idiopathic pulmonary fibrosis
por: Cheung, Wing Keung, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Clinical Predictors of Survival in Idiopathic Pulmonary Fibrosis
por: Kim, Ji Hye, et al.
Publicado: (2012)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

Workplace Injuries in Thoroughbred Racing: An Analysis of Insurance Payments and Injuries amongst Jockeys in Australia from 2002 to 2010
por: Curry, Beverley A., et al.
Publicado: (2015)

Physical Activity and Exertional Desaturation Are Associated with Mortality in Idiopathic Pulmonary Fibrosis
por: Vainshelboim, Baruch, et al.
Publicado: (2016)

Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality
por: Hyldgaard, Charlotte, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic
por: Faverio, P., et al.
Publicado: (2023)

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics
por: Cottin, Vincent, et al.
Publicado: (2021)

Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
por: Suissa, Samy, et al.
Publicado: (2022)

Association between timing of intubation and mortality in patients with idiopathic pulmonary fibrosis
por: Bae, Eunhye, et al.
Publicado: (2022)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

Clinical significance of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD): potential target for prevention of airway fibrosis and lung cancer
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2014)

Diagnosing interstitial lung disease by multidisciplinary discussion: A review
por: Glenn, Laura M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gm6i0geq27k2313cojoltaaf8n